Licensing Activities
Most of our activities are being conducted in alliance with partners including academia-industry cooperation and industry collaboration in Japan and overseas. We promote the in-licensing activity of development programs and developed products in our strong areas and focused fields, the in-licensing and out-licensing of useful products which contribute to the society, including unique drug formulations with additional value which meet customer needs as well as medical needs.
Intellectual Property (IP) Management
In our business activities, we endeavor to obtain, protect and utilize IP rights, including patents, in anticipation of global commercialization, licensing, collaborative research and other technical alliances. We also regularly conduct searching and evaluation of third-party's IP rights from the viewpoint of respecting their rights, and work to prevent IP risks in our businesses. We also carry out various IP-related assessments, especially when making important decisions, for example when deciding whether to move to the next stage of drug development. Also, with respect to new drug discovery modalities, including regenerative medicine products, we encourage the creation of intellectual property in anticipation of global expansion and promote the strategic utilization of intellectual property. The intellectual property of subsidiaries is also collectively managed and applied to facilitate utilization of intellectual property within the Group.